The use of bone morphogenetic protein in spine fusion
热1
dr.qinan 添加于 2009-5-23 20:41
| 1770 次阅读 | 0 个评论
作 者
Hsu WK, Wang JC 摘 要
BACKGROUND CONTEXT: Because pseudarthrosis remains a clinically significant complication after spinal arthrodesis, the role of recombinant bone morphogenetic proteins (BMPs) is continually evaluated in spine surgery. PURPOSE: This article reviews the important literature in clinical research involving the use of BMPs in the augmentation of spinal fusion. STUDY DESIGN/SETTING: Review article. METHODS: A literature search was performed via MEDLINE through PubMed with the dates January 1960 to July 2007 using the keywords "bone morphogenetic protein, BMP, spinal arthrodesis, and/or bone healing." Pertinent preclinical and clinical publications were chosen based on relevance and quality for inclusion in this study. RESULTS: Publications focused on the historical context and potential clinical applications using BMP were selected to delineate the risks, benefits, and current indications for the augmentation of spinal arthrodesis. CONCLUSIONS: Although multiple commercially available recombinant BMPs have demonstrated clinical success in interbody and posterolateral fusions, the associated costs preclude its routine use in spinal arthrodesis. The spine surgeon must assess each patient individually based on age, bone quality, diagnosis, comorbidities, and risks of nonunion to determine the cost effectiveness of the use of BMP to augment spinal fusion.-
详细资料
- 关键词: Animals; *Bone Morphogenetic Proteins; Humans; Recombinant Proteins; *Spinal Fusion
- 文献种类:期刊
- 期刊名称: The Spine Journal : Official Journal of the North American Spine Society
- 期刊缩写: Spine J
- 期卷页: 2008年 第8卷 第3期 419-425页
- 地址: Department of Orthopedic Surgery, and Rehabilitation, University of Wisconsin Madison, USA
- ISBN: 1529-9430
- 备注:PMID:18375186
评论( 人)
相关链接
DOI URL
Homozygous stop mutation in the SNX10 gene in a consanguineous Iraqi boy with osteopetrosis and corpus callosum hypoplasia
浙公网安备 33010202000686号 ( 浙ICP备09035230号-1 )
